The central aim of Sussex Health Outcomes, Research & Education in Cancer (SHORE-C) is to conduct pragmatic research in psychosocial oncology. Our work includes:
Measuring Quality of Life (QoL) in clinical trials of cancer therapy
Designing Patient Reported Outcome (PRO) measures
Developing and evaluating interventions to help patients deal with treatment side-effects
Producing educational materials and helping to improve communication skills of Cancer Healthcare Professionals
"Development and validation of the patient roles and responsibilities scale in cancer patients " Quality of Life Research
"Do drugs offering only PFS maintain quality of life sufficiently from a patient’s perspective? Results from AVALPROFS (Assessing the ‘VALue’ to patients of PROgression Free Survival) study " Supportive Care in Cancer
"Psychological Issues in Breast Cancer" in The Sixth Edition of The Companion to Specialist Surgery published by Elsevier
"RAZOR: A phase II open randomized trial of screening plus goserelin and raloxifene versus screening alone in premenopausal women at increased risk of breast cancer " Cancer Epidemiology Biomarkers and Prevention
"Quality of life and communication in orthognathic treatment" Journal of Orthodontics
"Cancer survivors’ experiences of a community-based cancer-specific exercise programme: results of an exploratory survey" Supportive Care in Cancer
"Enhancing decision-making about adjuvant chemotherapy in early breast cancer following EndoPredict testing" published by Psycho-Oncology
"EXTREQOL Identifies Ongoing Challenges in Maximising Quality of Survival in Men with Metastatic Castrate-Resistant Prostate Cancer" published by Clinical Oncology
“Patient-Centred Decision Making: Communication Challenges” Chapter 4 in Problem Solving in Patient-Centred and Integrated Cancer Care published by EBN Health Books
"Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: final analysis of the randomised, two-cohort PrefHer study" European Journal of Cancer
"Quality of Survival: a new concept framework to assess the quality of prolonged life in cancer" Expert Review of Quality of Life in Cancer Care
"Self-reported sexual health: Breast cancer survivors compared to women from the general population – an observational study" BioMed Central
"The Cost-effectiveness of Screening for Ovarian Cancer: Results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)" The British Journal of Cancer
"A new paradigm or a misrepresentation of current communication research and teaching." Letter to the Editor of Medical Education
"A user-centred approach to developing bWell, a mobile app for arm and shoulder exercises after breast cancer treatment." Journal of Cancer Survivorship
"The pervasive nature of uncertainty—a qualitative study of patients with advanced cancer and their informal caregivers." Journal of Cancer Survivorship
"Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial". The Breast
"Long-Term Follow-Up of the Intergroup Exemestane Study." Journal of Clinical Oncology
"The effect of ovarian cancer screening on sexual activity and functioning: results from the UK collaborative trial of ovarian cancer screening RCT" in British Journal of Cancer (restricted access/subscription required).
Chapter 18 “The Effects of Breast Cancer Treatments on Cognition” in Alistair Ring & Marina Parton (Eds) Breast Cancer Survivorship Springer
Too hot, too cold or can we get it just right? What emotional distance should oncologists keep from their patients? Read more
Patient-reported outcome measures of the impact of cancer on patients’ everyday lives: a systematic review. Read more
Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial. Read more
3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC3). Simultaneously published in Annals of Oncology and The Breast. Read more
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer. Read more
Sexual dysfunction in breast cancer survivors: cross-cultural adaptation of the Sexual Activity Questionnaire for use in Portugal. Read more
Elizabeth Hurley at SHORE-C
Elizabeth Hurley takes part in research into breast cancer treatment
The research is being carried out by Dame Lesley Fallowfield, Professor of Psycho-oncology at Brighton and Sussex Medical School, in partnership with Dr Melanie Flint, reader in cancer biology at the University of Brighton.
Elizabeth Hurley has taken part in research exploring the benefits of yoga, exercise and mindfulness on those being treated for breast cancer. See our bWell app for exercises after breast cancer, which you can download from the App Store.
The actress, 53, hailed the work as “ground-breaking” during a visit to the laboratory at Brighton and Sussex Medical School, where the team is exploring whether stress reduction techniques can increase the effectiveness of chemotherapy for those with breast cancer. Hurley, the global ambassador for Estee Lauder’s Pink Ribbon breast cancer awareness campaign, had her saliva tested to measure levels of the hormone cortisol, which indicates stress.
'Problem Solving in Person-Centred and Integrated Cancer Care' is the BMA Oncology Book of the Year!
Against significant competition from some excellent titles, ours was chosen as the best in category. The ACP series in oncology from EBN Health has won the award for the last three years which is a great achievement for all authors and editors. You can see the titles at www.ebnhealth.com.
Please email Duncan Enright, Managing Director, ebn health, for a copy of the book or more information
Talking about Risk and UncertaintieS of Testing IN Genetics (TRUSTING)
Professor Dame Lesley Fallowfield has been awarded a grant from the prestigious Breast Cancer Research Foundation in the US to develop a communication skills programme to help HCPs discuss germline mutations in breast cancer, and the management options available to patients.
Professor Val Jenkins and the Dame busy making a new patient information film with Prof Denis Talbot, Consultant medical oncologist at Oxford.
ECP Video - a great film production team!
Four of us went to BPOS (British Psychosocial Oncology Society) annual conference this year. Our director, Professor Dame Lesley Fallowfield, was awarded a BPOS Lifetime Membership Award. Lucy Matthews gave a talk on ENDOPREDICT and Rachel Starking displayed our PEPSIN poster. You can read more about the conference here.
Dr Helena Harder, Research Fellow at SHORE-C, in the news, telling us about her current research. Spotlight on Dr Helena Harder
Welcome to our new member of staff
SHORE-C is sorry to see the well-earned retirement of Tracy Woodcock, but welcomes Luke Murphy, our new Department Assistant to the team.
Dame Lesley and Professor Val Jenkins at the San Antonio Breast Cancer Symposium in December
For most women, being diagnosed with breast cancer causes significant emotional stress. The pressure of making important decisions about treatments, which often come with distressing side effects, can increase anxiety. Dame Lesley Fallowfield discussed her research into the psychological impact of breast cancer and showed how doctors can minimise stress by improving communication around risk and uncertainty of test results and recommended treatments.
An audio recording of Dame Lesley's talk is available on the Best of the British Festival of Science page on the BSMS website.